Filmon Emnetu, PharmD, is an Associate Director-Clinical Development Trial Leader at Eli Lilly and Company. He leads global Phase 3 clinical trials focused on investigational medicines in cardiometabolic health. His work involves designing and executing large-scale studies that help determine whether new therapies are safe and effective for patients.
I earned a Doctor of Pharmacy (PharmD) degree from Washington State University College of Pharmacy. After that, I completed a PGY1 pharmacy residency in pediatric acute care at Seattle Children’s Hospital and a Teaching Certificate in Pharmacy Education from the University of Washington. These experiences provided me with a strong foundation in patient care, leadership, and clinical pharmacology, which I now apply to drug development in the industry.
I work at Eli Lilly and Company, a global pharmaceutical company committed to discovering, developing, and delivering innovative medicines that make life better for people around the world. Lilly has a long legacy in advancing healthcare, and its mission to improve patient outcomes is at the core of everything we do.
I first became aware of Eli Lilly during pharmacy school, where we learned about its contributions to the field of medicine by researching new potential medicines. My interest deepened as I explored industry roles during my residency and my time in the SMDP program. Over time I discovered how pharmacists play a significant role in drug development and clinical research solidifying my passion for clinical research.
What I appreciate most is Lilly’s patient-centered culture and its investment in innovation. I’m inspired by the collaborative environment, the diversity of expertise across teams, and the company’s commitment to scientific excellence. Everyone is aligned around a shared goal of improving patients’ lives.
Strong communication, strategic thinking, clinical knowledge, and adaptability are key to success in my role. I chose this path because it allows me to make a broader impact beyond direct patient care—by helping to bring new therapies to patients globally through rigorous and meaningful research.
I define success as creating value for patients while growing both professionally and personally. Success is not just about outcomes, it’s also about how you get there: through ethical decision-making, teamwork, and continuous shared learning.
Knowing that the work we do today could change the standard of care tomorrow is incredibly fulfilling. It’s rewarding to be part of a process that translates scientific discovery into real-world therapies that improve patients’ quality of life all over the globe.
Be open to non-traditional paths and always stay motivated. Don’t be afraid to explore roles outside of your original field of study—your unique background can be a strength. Seek mentors, ask questions, and invest in building both technical and soft skills. The industry needs diverse thinkers and leaders.
Range by David Epstein. It’s a great read about how generalists thrive in a specialized world, and it really resonated with my own non-linear career path.